Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Evofem Biosciences, Inc. (EVFM)
|
|
| Balance Sheet |
|
|
|
| Standardized | As Reported |
Annual | Quarterly |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Assets |
| Cash and equivalents | 0.0 | 0.6 | 2.8 | 7.7 | 19.9 | 2.8 | 7.7 | 14.9 |
| Accounts receivable, net | 5.2 | 7.4 | 1.1 | 12.8 | 7.3 | 4.4 | 6.4 | 4.0 |
| Inventories | 3.7 | 5.5 | 5.4 | 5.2 | 5.9 | 5.4 | 7.7 | |
| Other current assets | 3.1 | 3.0 | 3.4 | 6.1 | 8.8 | 8.8 | 8.3 | 9.4 |
| Total current assets | 12.0 | 16.5 | 12.7 | 31.8 | 41.9 | 21.4 | 30.1 | 28.3 |
| Property, plant, and equipment, net | 1.7 | 3.7 | 3.9 | 4.3 | 5.3 | 5.5 | 5.8 | |
| Other fixed assets | 0.2 | 1.9 | 4.1 | 1.1 | 1.2 | 2.7 | 1.2 | |
| Total assets | 14.1 | 26.0 | 25.2 | 42.3 | 53.5 | 34.6 | 42.5 | 28.3 |
| |
| Accounts payable | 17.2 | 18.8 | 15.0 | 14.5 | 15.4 | 14.0 | 10.3 | |
| Accrued expenses | 4.2 | 3.5 | 4.1 | 5.5 | 6.9 | 9.7 | 8.4 | |
| Short-term and curr portion of long-term debt [+] | 15.6 | 23.8 | 0.0 | 0.0 | 4.1 | 0.3 | 0.0 | 0.0 |
| Short-term debt | | | | | 4.1 | 0.3 | | |
| Current portion of long-term debt | 15.6 | 23.8 | | | | | | |
| Other current liabilities | 32.7 | 33.8 | 74.7 | 96.7 | 239.2 | 130.4 | 119.0 | 94.7 |
| Total current liabilities | 69.7 | 79.8 | 93.8 | 116.7 | 265.6 | 154.5 | 137.7 | 94.7 |
| Other liabilities | 0.0 | 2.6 | 3.1 | 3.6 | 3.9 | 4.1 | 4.4 | 31.6 |
| Total liabilities | 69.7 | 82.4 | 97.0 | 120.3 | 269.5 | 158.5 | 142.1 | 126.3 |
| |
| Shareholders' equity [+] | -55.7 | -56.4 | -71.8 | -78.0 | -216.0 | -124.0 | -99.6 | -98.0 |
| Paid-in capital | 820.6 | 819.7 | 817.4 | 815.3 | 802.3 | 759.2 | 751.3 | |
| Retained earnings | -949.6 | -941.0 | -938.7 | -930.4 | -1,019.9 | -892.6 | -860.7 | |
| Tangible shareholders' equity | -55.7 | -56.4 | -71.8 | -78.0 | -216.0 | -124.0 | -99.6 | -98.0 |
|